Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$67.49 -2.8%	$66.72	$43.56 ▼ $72.51	$85.09B	0.57	11.56 million shs	14.30 million shs
ISRG Intuitive Surgical	$529.42 +2.4%	$504.32	$378.87 ▼ $616.00	$189.75B	1.55	1.62 million shs	1.44 million shs
JNJ Johnson & Johnson	$156.09 +1.1%	$158.85	$140.68 ▼ $169.99	$375.56B	0.49	7.88 million shs	5.97 million shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	-2.77%	+3.35%	-0.95%	+19.39%	+19.83%
ISRG Intuitive Surgical	+2.37%	+2.88%	+4.41%	-7.42%	+42.43%
JNJ Johnson & Johnson	+1.08%	+1.00%	+0.44%	+2.63%	+3.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVS CVS Health	4.9074 of 5 stars	2.5	3.0	3.3	3.9	3.8	3.3	3.1
ISRG Intuitive Surgical	4.6945 of 5 stars	3.4	4.0	0.0	4.0	3.3	2.5	1.9
JNJ Johnson & Johnson	4.7293 of 5 stars	3.3	3.0	4.2	3.9	3.3	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.90	Moderate Buy	$72.87	7.97% Upside
ISRG Intuitive Surgical	2.75	Moderate Buy	$598.95	13.13% Upside
JNJ Johnson & Johnson	2.63	Moderate Buy	$171.82	10.08% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ISRG, and CVS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/2/2025	CVS CVS Health	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$67.00 ➝ $71.00
5/2/2025	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$73.00 ➝ $82.00
4/24/2025	ISRG Intuitive Surgical	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$684.00 ➝ $635.00
4/24/2025	JNJ Johnson & Johnson	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/23/2025	ISRG Intuitive Surgical	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$630.00 ➝ $605.00
4/23/2025	ISRG Intuitive Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$670.00 ➝ $575.00
4/23/2025	ISRG Intuitive Surgical	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$605.00 ➝ $590.00
4/23/2025	ISRG Intuitive Surgical	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$510.00 ➝ $470.00
4/23/2025	ISRG Intuitive Surgical	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$600.00 ➝ $575.00
4/17/2025	JNJ Johnson & Johnson	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$166.00 ➝ $165.00
4/16/2025	JNJ Johnson & Johnson	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform

(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$372.81B	0.23	$9.43 per share	7.16	$60.06 per share	1.12
ISRG Intuitive Surgical	$8.71B	21.77	$6.97 per share	75.93	$46.41 per share	11.41
JNJ Johnson & Johnson	$89.33B	4.20	$12.83 per share	12.17	$29.69 per share	5.26

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$4.61B	$3.66	18.44	9.97	0.98	1.24%	9.11%	2.71%	N/A
ISRG Intuitive Surgical	$2.32B	$6.82	82.59	69.39	5.85	27.81%	14.55%	12.88%	7/17/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$8.99	23.47	14.10	2.56	18.20%	34.24%	13.63%	7/16/2025 (Estimated)

Latest JNJ, ISRG, and CVS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2025	Q1 2025	CVS CVS Health	$1.62	$2.25	+$0.63	$1.41	$93.07 billion	$94.59 billion
4/22/2025	Q1 2025	ISRG Intuitive Surgical	$1.71	$1.81	+$0.10	$1.92	$2.19 billion	$2.25 billion
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion
2/12/2025	Q4 2024	CVS CVS Health	$0.89	$1.19	+$0.30	$1.30	$96.90 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	3.94%	+9.97%	72.68%	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$5.20	3.33%	+5.43%	57.84%	64 Years

Latest JNJ, ISRG, and CVS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025
3/20/2025	CVS CVS Health	quarterly	$0.6650	3.89%	4/22/2025	4/22/2025	5/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.80	0.81	0.60
ISRG Intuitive Surgical	N/A	4.07	3.22
JNJ Johnson & Johnson	0.43	1.11	0.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
ISRG Intuitive Surgical	83.64%
JNJ Johnson & Johnson	69.55%

Insider Ownership

Company	Insider Ownership
CVS CVS Health	1.22%
ISRG Intuitive Surgical	0.70%
JNJ Johnson & Johnson	0.16%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.26 billion	1.26 billion	Optionable
ISRG Intuitive Surgical	12,100	358.42 million	352.97 million	Optionable
JNJ Johnson & Johnson	152,700	2.41 billion	2.40 billion	Optionable

JNJ, ISRG, and CVS Headlines

Recent News About These Companies

Zacks Research Has Optimistic Outlook of JNJ FY2025 Earnings

May 3 at 8:11 AM | marketbeat.com

Allegheny Financial Group Sells 2,675 Shares of Johnson & Johnson (NYSE:JNJ)

May 3 at 7:54 AM | marketbeat.com

4WEALTH Advisors Inc. Takes Position in Johnson & Johnson (NYSE:JNJ)

May 3 at 7:22 AM | marketbeat.com

Wahed Invest LLC Buys 3,807 Shares of Johnson & Johnson (NYSE:JNJ)

May 3 at 6:25 AM | marketbeat.com

Pennington Partners & CO. LLC Makes New $415,000 Investment in Johnson & Johnson (NYSE:JNJ)

May 3 at 6:17 AM | marketbeat.com

Johnson & Johnson (NYSE:JNJ) Stock Position Increased by Hutner Capital Management Inc.

May 3 at 6:17 AM | marketbeat.com

Johnson & Johnson (NYSE:JNJ) Trading 0.5% Higher - Here's Why

May 3 at 4:35 AM | marketbeat.com

Johnson & Johnson - Elliott Wave Technical Analysis

May 2 at 7:39 PM | talkmarkets.com

Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting MedTech

May 2 at 1:34 PM | tipranks.com

South Plains Financial Inc. Invests $1.46 Million in Johnson & Johnson (NYSE:JNJ)

May 2 at 8:31 AM | marketbeat.com

Cypress Advisory Group LLC Buys New Shares in Johnson & Johnson (NYSE:JNJ)

May 2 at 7:49 AM | marketbeat.com

Johnson & Johnson (NYSE:JNJ) Shares Sold by Mercer Global Advisors Inc. ADV

May 2 at 7:47 AM | marketbeat.com

J&J Steps Into Crowded Myasthenia Gravis Market With FDA Nod

May 2 at 7:44 AM | biospace.com

HistoSonics reportedly eyes sale at $2.5B valuation with Medtronic, GE HealthCare, J&J interest

May 2 at 7:44 AM | massdevice.com

Keel Point LLC Has $4.51 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

May 2 at 7:41 AM | marketbeat.com

Sulzberger Capital Advisors Inc. Takes $453,000 Position in Johnson & Johnson (NYSE:JNJ)

May 2 at 7:10 AM | marketbeat.com

Caisse DE Depot ET Placement DU Quebec Sells 352,581 Shares of Johnson & Johnson (NYSE:JNJ)

May 2 at 7:07 AM | marketbeat.com

J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy

May 2 at 2:43 AM | fiercepharma.com

J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

May 2 at 12:17 AM | reuters.com

Johnson & Johnson (NYSE:JNJ) Stock Price Up 0% - Still a Buy?

May 1 at 1:45 PM | marketbeat.com

Johnson & Johnson (NYSE:JNJ) Stake Raised by RBO & Co. LLC

May 1 at 8:19 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Are Tariffs Threatening Disney’s Comeback Story?
By Jea Yu | April 9, 2025
View Are Tariffs Threatening Disney’s Comeback Story?
Top 3 S&P 500 Winners in a Losing Market
By Ryan Hasson | April 9, 2025
View Top 3 S&P 500 Winners in a Losing Market
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
By Leo Miller | April 28, 2025
View 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?
By Chris Markoch | April 16, 2025
View Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?
Is Intuitive Surgical a Buy After Volatile Reaction to Earnings?
By Chris Markoch | April 25, 2025
View Is Intuitive Surgical a Buy After Volatile Reaction to Earnings?

JNJ, ISRG, and CVS Company Descriptions

CVS Health NYSE:CVS

$67.49 -1.96 (-2.82%)

Closing price 05/2/2025 03:59 PM Eastern

Extended Trading

$67.40 -0.09 (-0.14%)

As of 05/2/2025 07:58 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Intuitive Surgical NASDAQ:ISRG

$529.42 +12.24 (+2.37%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$528.04 -1.38 (-0.26%)

As of 05/2/2025 07:54 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson NYSE:JNJ

$156.09 +1.63 (+1.06%)

Closing price 05/2/2025 03:59 PM Eastern

Extended Trading

$155.98 -0.12 (-0.07%)

As of 05/2/2025 07:50 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time